Lesley Cala

Clinical Professor

  • The University of Western Australia (M504), 35 Stirling Highway,

    6009 Perth

    Australia

  • 2006 Citations
  • 20 h-Index
1972 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Lesley Cala is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Tomography Medicine & Life Sciences
Stroke Medicine & Life Sciences
Tissue Plasminogen Activator Medicine & Life Sciences
Multiple Sclerosis Medicine & Life Sciences
Atrophy Medicine & Life Sciences
Brain Medicine & Life Sciences
Cerebral Hemorrhage Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1972 2019

6 Citations (Scopus)

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

RIGHT-2 Investigators & Cala, L., 9 Mar 2019, In : Lancet. 393, 10175, p. 1009-1020 12 p.

Research output: Contribution to journalArticle

Open Access
Ambulances
Nitroglycerin
Stroke
Allied Health Personnel
Blood Pressure

Blood pressure variability and leukoaraiosis in acute ischemic stroke

Dickie, D. A., Aribisala, B., Mair, G., Berge, E., Lindley, R. I., Sandercock, P., von Kummer, R., von Heijne, A., Peeters, A., Cala, L., Farrall, A., Morris, Z., Bradey, N., Potter, G., Adami, A. & Wardlaw, J. M., 1 Jul 2018, In : International Journal of Stroke. 13, 5, p. 473-480 8 p.

Research output: Contribution to journalArticle

Leukoaraiosis
Stroke
Blood Pressure
Random Allocation
Atrophy

Effect of IV alteplase on the ischemic brain lesion at 24-48 hours after ischemic stroke

IST-3 collaborative group, 27 Nov 2018, In : Neurology. 91, 22, p. e2067-e2077

Research output: Contribution to journalArticle

Open Access
Tissue Plasminogen Activator
Stroke
Brain
Odds Ratio
Confidence Intervals
42 Citations (Scopus)

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

TICH-2 Investigators & Cala, L. A., 26 May 2018, In : The Lancet. 391, 10135, p. 2107-2115

Research output: Contribution to journalArticle

Open Access
Tranexamic Acid
Cerebral Hemorrhage
Placebos
Stroke
Odds Ratio
Open Access